The aim of this study was to investigate the role of the synaptic metabotropic zinc receptor mZnR/GPR39 in physiological adaptation to epileptic seizures. We previously demonstrated that synaptic activation of mZnR/GPR39 enhances inhibitory drive in the hippocampus by upregulating neuronal K + /Cl − cotransporter 2 (KCC2) activity. Here, we first show that mZnR/GPR39 knockout (KO) adult mice have dramatically enhanced susceptibility to seizures triggered by a single intraperitoneal injection of kainic acid, when compared to wild type (WT) littermates. Kainate also substantially enhances seizureassociated gamma oscillatory activity in juvenile mZnR/GPR39 KO hippocampal slices, a phenomenon that can be reproduced in WT tissue by extracellular Zn 2+ chelation. Importantly, kainate-induced synaptic Zn 2+ release enhances surface expression and transport activity of KCC2 in WT, but not mZnR/GPR39 KO hippocampal neurons. Kainate-dependent upregulation of KCC2 requires mZnR/GPR39 activation of the Gαq/phospholipase C/extracellular regulated kinase (ERK1/2) signaling cascade. We suggest that mZnR/ GPR39-dependent upregulation of KCC2 activity provides homeostatic adaptation to an excitotoxic stimulus by increasing inhibition. As such, mZnR/GPR39 may provide a novel pharmacological target for dampening epileptic seizure activity.
Introduction

Zn
2+ is the second most prevalent trace element in the human body, distributed widely throughout the brain (Frederickson et al., 2005; Sensi et al., 2011) and selectively stored within presynaptic vesicles in a sub-population of excitatory neurons by the neuronal-specific zinc transporter ZnT3 (Cole et al., 1999 (Cole et al., , 2000 Sensi et al., 2011) . Vesicular Zn 2+ is co-released with glutamate into the synaptic cleft in a Ca 2+ -and activity-dependent manner (Li et al., 2001; Qian and Noebels, 2005; Paoletti et al., 2008; Perez-Rosello et al., 2013; Vergnano et al., 2014) . Synaptically-released Zn 2+ has been suggested to regulate neuronal excitability and modulate the severity of seizure activity (Vogt et al., 2000; Smart et al., 2004; Sensi et al., 2009) . Indeed, genetic removal of synaptic Zn 2+ via ZnT3 deletion leads to enhanced susceptibility to epileptic seizures (Cole et al., 1999 (Cole et al., , 2000 , and importantly, deficiencies in plasma Zn 2+ levels have been associated with human epileptic disorders (Goldberg and Sheehy, 1982; Blasco-Ibanez et al., 2004; Ganesh and Janakiraman, 2008; Farahani et al., 2013; Seven et al., 2013; Wojciak et al., 2013; Saad et al., 2014) . Moreover, studies in kindling models of epilepsy suggest that seizure activity can be moderated via Zn 2+ administration (Elsas et al., 2009; Baraka et al., 2012) . Nonetheless, the pathways linking synaptically released Zn 2+ to regulation of seizure activity are poorly understood. The metabotropic Zn 2+ -sensing receptor (mZnR/GPR39) has previously been suggested to be present in the soma and dendrites of pyramidal neurons in the CA3 region of the hippocampus (Jackson et al., 2006; Besser et al., 2009 ). This receptor is activated by synaptic Zn 2+ released from the mossy fibers and triggers an intracellular Ca 2+ rise in hippocampal CA3 neurons, but not glia (Besser et al., 2009 ). Activation of mZnR/GPR39 signaling leads to upregulation of K + /Cl − co-transporter 2 (KCC2) surface expression and activity (Chorin et al., 2011; Saadi et al., 2012) . As KCC2 is the major Cl − extruding transporter in neurons, responsible for hyperpolarizing currents mediated by GABA A receptor channel activation (Rivera et al., 1999; Zhu et al., 2005; Viitanen et al., 2010) , a hyperpolarizing shift in the GABA reversal potential was measured in pyramidal CA3 neurons following exposure to Zn 2+ (Chorin et al., 2011 ).
KCC2 activity is essential for regulating neuronal inhibitory drive (Blaesse et al., 2009 ). KCC2 expression, induced during the first two postnatal weeks (Rivera et al., 1999; Ludwig et al., 2003; Stein et al., 2004) , correlates with the developmental switch from depolarizing to Neurobiology of Disease 81 (2015) 4-13 
